Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist

British Journal of Pharmacology

Volumn 121, Issue 8, 1997, Pages 1716-1720

  Fernando, Susanthi R ^a   Pertwee, Roger G ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

9 tetrahydrocannabinol; Cannabinoid receptor agonists; Cannabinoid receptor antagonist; Guinea pig small intestine; Methyl arachidonyl fluorophosphonate; Myenteric plexus

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACETYLCHOLINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CLONIDINE; DRONABINOL; FLUOROPHOSPHATE; METHANANDAMIDE; METHYLARACHIDONYLFLUORPHOSPHONATE; NABILONE; NORMORPHINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GUINEA PIG; MALE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE TWITCH; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE;

ANIMALS; ARACHIDONIC ACIDS; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; INTESTINE, SMALL; MALE; MUSCLE CONTRACTION; PHOSPHONIC ACIDS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0030759362     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701303     Document Type: Article

References (16)

1. ABADJI, V., LIN, S., TAHA, G., GRIFFIN, G., STEVENSON, L.A., PERTWEE, R.G. & MAKRIYANNIS, A.(1994). (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J. Med. Chem., 37, 1889-1893.
2. ALEXANDER, S.P.H. & PETERS, J.A. (1997). 1997 receptor and ion channel nomenclature supplement. In Trends Pharmacol Sci., 8th Edition, Cambridge: Elsevier.
3. COLQUHOUN, D. (1971). Lectures on Biostatistics. Oxford: Oxford University Press.
4. COWIE, A.L., KOSTERLITZ, H.W. & WATERFIELD, A.A. (1978). Factors influencing the release of acetylcholine from the myenteric plexus of the ileum of the guinea-pig and rabbit. Br. J. Pharmacol., 64, 565-580.
5. CRAVATT, B.F., GIANG, D.K., MAYFIELD, S.P., BOGER, D.L., LERNER, R.A. & GILULA, N.B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 83-87.
6. DEUTSCH, D.G., OMEIR, R., ARREAZA, G., SALEHANI, D., PRESTWICH, G.D., HUANG, Z. & HOWLETT, A. (1997). Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem. Pharmacol., 53, 255-260.
7. 2. Biochemistry, 35, 3712-3721.
8. KENAKIN, T.P. (1993). Pharmacologic Analysis of Drug-Receptor Interaction. 2nd Edition. New York: Raven Press.
9. PATERSON, S.J. & PERTWEE, R.G. (1993). Characterization of the cannabinoid binding site in the guinea-pig. Br. J. Pharmacol. (Proc. suppl.), 109, 82P.
10. PATON, W.D.M. & ZAR, M.A. (1968). The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J. Physiol., 194, 13-33.
11. PERTWEE, R.G. (1996). Cannabinoid receptor ligands: clinical and neuropharmacological considerations relevant to future drug discovery and development. Exp. Opin. Invest. Drugs, 5, 1245-1253.
12. PERTWEE, R.G., FERNANDO, S.R., GRIFFIN, G., ABADJI, V. & MAKRIYANNIS, A. (1995). Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur. J. Pharmacol., 272, 73-78.
13. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol., 118, 2199-2205.
14. PERTWEE, R.G., STEVENSON, L.A., ELRICK, D.B., MECHOULAM, R. & CORBETT, A.D. (1992). Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br. J. Pharmacol., 105, 980-984.
15. RINALDI-CARMONA, M., BARTH, F., HEAULME, M., SHIRE, D., CALANDRA, B., CONGY, C., MARTINEZ, S., MARUANI, J., NELIAT, G., CAPUT, D., FERRARA, P., SOUBRIE, P., BRELIERE, J.C. & LE FUR, G. (1994). SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett., 350, 240-244.
16. SONG, Z.-H. & BONNER, T.I. (1996). A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. Mol. Pharmacol., 49, 891-896.